Developing science-led women’s health products informed by microbiome research
Women’s health remains underrepresented in research and product development, leaving important biological differences and life-stage needs less well addressed. Research into the microbiome, gut and brain may offer new ways to build products that are better informed by women’s biology.
FemmeBiome is a developing women’s health products informed by microbiome, gut and brain research. Its first product, MoreMe, combines probiotics and a prebiotic in a daily supplement for women navigating perimenopause and menopause.
What stands out about FemmeBiome
FemmeBiome’s research-led development received over €700,000 in Enterprise Ireland feasibility and commercialisation grants.
FemmeBiome’s founder reports an eight-week human trial of its initial gut-health supplement before the planned market launch.
University College Cork announced FemmeBiome's spin-out, translating APC microbiome research into women's health products.
Enterprise Ireland's Pre-Seed Start Fund supports FemmeBiome, separately from its grants and prospective seed round.
Founder Siobhain O’Mahony is a UCC neurobiology professor with directly relevant microbiome-gut-brain research expertise.
Participated in Food Works, an accelerator programme for Irish food and drink startups, while developing its supplement business.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.